VIVANZA quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Vivanza Biosciences Ltd reported sales of ₹9.29 Cr, operating profit of ₹-0.07 Cr (OPM -0.75%) and net profit of ₹0.15 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
VIVANZA quarterly results (₹ Cr)
Metric
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
3
1.5
0.48
8.94
55.36
45.25
6.36
9.29
YoY Sales growth
-60.63
-77.13
-89.14
266.39
1,745.33
2,916.67
1,225
3.91
Expenses
2.89
1.37
1.44
8.79
54.75
45.04
6.59
9.36
Operating Profit
0.11
0.13
-0.96
0.15
0.61
0.21
-0.23
-0.07
OPM
3.67%
8.67%
-200%
1.68%
1.1%
0.46%
-3.62%
-0.75%
Other Income
0
0.01
0.05
0.02
0.01
0.08
0.01
0.37
Interest
0.09
0.09
0.08
0.08
0.05
0.09
0.07
0.11
Depreciation
0
0
0
0
0
0
0.01
0.01
Profit before tax
0.02
0.05
-0.99
0.09
0.57
0.2
-0.3
0.18
Tax
0%
0%
1.01%
0%
0%
0%
50%
22.22%
Net Profit
0.02
0.04
-1
0.09
0.56
0.2
-0.45
0.15
EPS in Rs
0
0.01
-0.25
0.02
0.14
0.05
-0.11
0.04
VIVANZA profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
10
18
28
7
116
116
Sales growth
5
71
56
-73
1,468
735
Expenses
10
17
27
8
115
116
Operating Profit
0
1
1
0
1
1
OPM
-0.6%
3.8%
3.9%
-4.9%
0.6%
0.5%
Other Income
1
0
0
0
0
0
Interest
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
Profit before tax
0
1
1
-1
1
1
Tax
0%
17%
21%
2%
27%
-
Net Profit
0
1
1
-1
0
0
EPS in Rs
0.08
0.15
0.14
-0.17
0.1
0.12
Dividend Payout
0%
0%
0%
0%
0%
-
VIVANZA balance sheet (₹ Cr)
Metric
Mar 2023
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Equity Capital
4
4
4
4
4
Reserves
0
1
0
1
0
Borrowings
8
5
9
10
10
Other Liabilities
10
10
4
35
8
Total Liabilities
22
20
16
50
22
Fixed Assets
2
2
2
2
2
CWIP
0
0
0
0
0
Investments
0
0
0
0
0
Other Assets
20
17
14
47
20
Total Assets
22
20
16
50
22
VIVANZA cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
2
-1
2
-2
-3
Cash from Investing Activity
0
0
0
0
0
Cash from Financing Activity
-2
1
-2
2
3
Net Cash Flow
0
0
0
0
0
Free Cash Flow
2
-1
2
-3
-3
CFO/OP
-4,117%
-124%
203%
692%
-328%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit